Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
This study is looking to determine if Lumateperone improves motivation in patients with schizophrenia or schizoaffective disorders who show high levels of apathy as judged by AES-C-Apathy (Apathy Evaluation Scale - Clinician - Apathy) assessment and to examine a possible correlation between improvement in apathy scores and changes in elements of the PANSS (Positive and Negative Syndrome Scale) due to treatment with Lumateperone.
Epistemonikos ID: eb9b3ca825ade51e562d2d4609a7771c4d745e90
First added on: Apr 17, 2025